Schizophrenia: Using Digital Biomarkers to Measure Quality of Life
By Cambridge Cognition
The symptoms of schizophrenia spectrum illnesses are multifaceted and vary greatly over time. For a successful clinical trial, it is vital to accurately assess and monitor symptoms and how they impact day-to-day life. Learn how digital biomarkers are used objectively and practically to measure quality of life indicators important to patients in our whitepaper.